| 000 | 01068 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516161620.0 | ||
| 264 | 0 | _c20131209 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1365-2141 | ||
| 024 | 7 |
_a10.1111/bjh.12477 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZojer, Niklas | |
| 245 | 0 | 0 |
_aCereblon expression in multiple myeloma: not ready for prime time - response to Lodé et al. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cOct 2013 |
||
| 300 |
_a285-6 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aPeptide Hydrolases _xbiosynthesis |
| 700 | 1 | _aHeintel, Daniel | |
| 700 | 1 | _aPalumbo, Antonio | |
| 700 | 1 | _aLudwig, Heinz | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 163 _gno. 2 _gp. 285-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjh.12477 _zAvailable from publisher's website |
| 999 |
_c22931639 _d22931639 |
||